HLA-C and cancer: The glycoprotein receptors/proteins encoded by the major histocompatibility complex (MHC) are expressed on the surface of the antigen presenting cells (APCs) bound with ligands (processed antigens) and are recognized by T cells, which kill the cancer cells through TCR engagement with the neoantigen.